WHITTIER TRUST CO OF NEVADA INC
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1263548
RENO, NV
Position in REGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$42,400
-$10,912 QoQ
Shares Held
68
-1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,137
of 1,329 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WHITTIER TRUST CO OF NEVADA INC holds $867,253 across 28 Biotechnology names. REGN ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
546 | $271,214 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
10,200 | $152,388 | |
| 3 | ANRO |
Alto Neuroscience, Inc.
|
2,482 | $65,499 | |
| 4 | TECH |
BIO-TECHNE Corp
|
830 | $58,639 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
184 | $55,389 | |
| 6 | CGON |
CG Oncology, Inc.
|
666 | $47,319 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
68 | $42,400 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
375 | $29,351 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,400 | 68 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $53,312 | 69 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $40,909 | 53 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $45,543 | 81 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $67,200 | 128 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $69,765 | 110 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $84,054 | 118 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $175,557 | 167 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $177,624 | 169 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $129,936 | 135 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $144,917 | 165 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $135,788 | 165 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $118,559 | 165 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $135,575 | 165 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $120,488 | 167 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $77,153 | 112 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $32,512 | 55 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $38,413 | 55 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $18,945 | 30 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $18,155 | 30 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $16,756 | 30 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $14,194 | 30 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $14,493 | 30 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $16,793 | 30 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $18,709 | 30 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $14,648 | 30 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||